메뉴 건너뛰기




Volumn 62, Issue 1, 2010, Pages 12-19

Cardiovascular safety assessments in the conscious telemetered dog: Utilisation of super-intervals to enhance statistical power

Author keywords

Ambulatory telemetry; Cardiovascular safety; Conscious Beagle dog; Doxazosin; Methods; Moxifloxacin; Power analysis and super interval

Indexed keywords

DOXAZOSIN; MOXIFLOXACIN;

EID: 77955931471     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2010.05.011     Document Type: Article
Times cited : (45)

References (28)
  • 1
    • 0032982723 scopus 로고    scopus 로고
    • Moxifloxacin
    • discussion 374
    • Balfour J.A., Wiseman L.R. Moxifloxacin. Drugs 1999, 57:363-373. discussion 374.
    • (1999) Drugs , vol.57 , pp. 363-373
    • Balfour, J.A.1    Wiseman, L.R.2
  • 3
    • 34548483458 scopus 로고    scopus 로고
    • ILSI-HESI cardiovascular safety subcommittee dataset: an analysis of the statistical properties of QT interval and rate-corrected QT interval (QTc)
    • Chiang A.Y., Bass A.S., Cooper M.M., Engwall M.J., Menton R.G., Thomas K. ILSI-HESI cardiovascular safety subcommittee dataset: an analysis of the statistical properties of QT interval and rate-corrected QT interval (QTc). Journal of Pharmacological and Toxicological Methods 2007, 56:95-102.
    • (2007) Journal of Pharmacological and Toxicological Methods , vol.56 , pp. 95-102
    • Chiang, A.Y.1    Bass, A.S.2    Cooper, M.M.3    Engwall, M.J.4    Menton, R.G.5    Thomas, K.6
  • 5
    • 0028306578 scopus 로고
    • Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease
    • Collins R., Macmahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. British Medical Bulletin 1994, 50:272-298.
    • (1994) British Medical Bulletin , vol.50 , pp. 272-298
    • Collins, R.1    Macmahon, S.2
  • 6
    • 0031705780 scopus 로고    scopus 로고
    • Anatomy of the pig heart: Comparisons with normal human cardiac structure
    • Crick S.J., Sheppard M.N., Ho S.Y., Gebstein L., Anderson R.H. Anatomy of the pig heart: Comparisons with normal human cardiac structure. Journal of Anatomy 1998, 193(Pt 1):105-119.
    • (1998) Journal of Anatomy , vol.193 , Issue.PART 1 , pp. 105-119
    • Crick, S.J.1    Sheppard, M.N.2    Ho, S.Y.3    Gebstein, L.4    Anderson, R.H.5
  • 7
    • 33644551239 scopus 로고    scopus 로고
    • Electrocardiogram, hemodynamics, and core body temperatures of the normal freely moving laboratory beagle dog by remote radiotelemetry
    • Gauvin D.V., Tilley L.P., Smith F.W., Baird T.J. Electrocardiogram, hemodynamics, and core body temperatures of the normal freely moving laboratory beagle dog by remote radiotelemetry. Journal of Pharmacological and Toxicological Methods 2006, 53:128-139.
    • (2006) Journal of Pharmacological and Toxicological Methods , vol.53 , pp. 128-139
    • Gauvin, D.V.1    Tilley, L.P.2    Smith, F.W.3    Baird, T.J.4
  • 8
    • 2542432906 scopus 로고    scopus 로고
    • Developing a strategy for the nonclinical assessment of proarrhythmic risk of pharmaceuticals due to prolonged ventricular repolarization
    • Guth B.D., Germeyer S., Kolb W., Markert M. Developing a strategy for the nonclinical assessment of proarrhythmic risk of pharmaceuticals due to prolonged ventricular repolarization. Journal of Pharmacological and Toxicological Methods 2004, 49:159-169.
    • (2004) Journal of Pharmacological and Toxicological Methods , vol.49 , pp. 159-169
    • Guth, B.D.1    Germeyer, S.2    Kolb, W.3    Markert, M.4
  • 12
    • 20444456763 scopus 로고    scopus 로고
    • A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data
    • Jonker D.M., Kenna L.A., Leishman D., Wallis R., Milligan P.A., Jonsson E.N. A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data. Clinical Pharmacology and Therapeutics 2005, 77:572-582.
    • (2005) Clinical Pharmacology and Therapeutics , vol.77 , pp. 572-582
    • Jonker, D.M.1    Kenna, L.A.2    Leishman, D.3    Wallis, R.4    Milligan, P.A.5    Jonsson, E.N.6
  • 13
    • 0035170062 scopus 로고    scopus 로고
    • Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG
    • Kang J., Wang L., Chen X.L., Triggle D.J., Rampe D. Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG. Molecular Pharmacology 2001, 59:122-126.
    • (2001) Molecular Pharmacology , vol.59 , pp. 122-126
    • Kang, J.1    Wang, L.2    Chen, X.L.3    Triggle, D.J.4    Rampe, D.5
  • 16
    • 23944523005 scopus 로고    scopus 로고
    • Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia
    • Logan Y.T., Belgeri M.T. Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia. The American Journal of Geriatric Pharmacotherapy 2005, 3:103-114.
    • (2005) The American Journal of Geriatric Pharmacotherapy , vol.3 , pp. 103-114
    • Logan, Y.T.1    Belgeri, M.T.2
  • 17
    • 4644244216 scopus 로고    scopus 로고
    • A novel propellant-free inhalation drug delivery system for cardiovascular drug safety evaluation in conscious dogs
    • Markert M., Klumpp A., Trautmann T., Guth B. A novel propellant-free inhalation drug delivery system for cardiovascular drug safety evaluation in conscious dogs. Journal of Pharmacological and Toxicological Methods 2004, 50:109-119.
    • (2004) Journal of Pharmacological and Toxicological Methods , vol.50 , pp. 109-119
    • Markert, M.1    Klumpp, A.2    Trautmann, T.3    Guth, B.4
  • 18
    • 1842559970 scopus 로고    scopus 로고
    • Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS)
    • Mason P.J., Manson J.E., Sesso H.D., Albert C.M., Chown M.J., Cook N.R., et al. Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS). Circulation 2004, 109:1623-1629.
    • (2004) Circulation , vol.109 , pp. 1623-1629
    • Mason, P.J.1    Manson, J.E.2    Sesso, H.D.3    Albert, C.M.4    Chown, M.J.5    Cook, N.R.6
  • 22
    • 0035968627 scopus 로고    scopus 로고
    • Blood-pressure lowering for the secondary prevention of stroke
    • Staessen J.A., Wang J. Blood-pressure lowering for the secondary prevention of stroke. Lancet 2001, 358:1026-1027.
    • (2001) Lancet , vol.358 , pp. 1026-1027
    • Staessen, J.A.1    Wang, J.2
  • 25
    • 34548513789 scopus 로고    scopus 로고
    • Evaluation of blood flow parameters in addition to blood pressure and electrocardiogram in the conscious telemetered beagle dog
    • Taylor G.L., Patel B., Sullivan A.T. Evaluation of blood flow parameters in addition to blood pressure and electrocardiogram in the conscious telemetered beagle dog. Journal of Pharmacological and Toxicological Methods 2007, 56:212-217.
    • (2007) Journal of Pharmacological and Toxicological Methods , vol.56 , pp. 212-217
    • Taylor, G.L.1    Patel, B.2    Sullivan, A.T.3
  • 26
    • 33645062178 scopus 로고    scopus 로고
    • QT PRODACT: in vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals
    • Toyoshima S., Kanno A., Kitayama T., Sekiya K., Nakai K., Haruna M., et al. QT PRODACT: in vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals. Journal of Pharmacological Sciences 2005, 99:459-471.
    • (2005) Journal of Pharmacological Sciences , vol.99 , pp. 459-471
    • Toyoshima, S.1    Kanno, A.2    Kitayama, T.3    Sekiya, K.4    Nakai, K.5    Haruna, M.6
  • 27
    • 74549140187 scopus 로고    scopus 로고
    • Integrated risk assessment and predictive value to humans of non-clinical repolarization assays
    • Wallis R.M. Integrated risk assessment and predictive value to humans of non-clinical repolarization assays. British Journal of Pharmacology 2009, 159:115-121.
    • (2009) British Journal of Pharmacology , vol.159 , pp. 115-121
    • Wallis, R.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.